肝脏恶性肿瘤的临床试验
总计3897个结果
-
The First Affiliated Hospital of Guangzhou Medical...Sinotau Pharmaceutical Group完全的
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.邀请报名
-
M.D. Anderson Cancer CenterEisai Inc.撤销晚期癌症 | 女性生殖器恶性肿瘤 | 乳腺恶性肿瘤 | 不明确的次要和未指定部位的恶性肿瘤 | 唇口咽部恶性肿瘤 | 独立(原发)多部位恶性肿瘤 | 间皮和软组织恶性肿瘤 | 甲状腺和其他内分泌腺恶性肿瘤 | 泌尿系恶性肿瘤 | 消化器官恶性肿瘤 | 男性生殖器恶性肿瘤 | 眼脑及中枢神经系统其他部位的恶性肿瘤 | 呼吸系统和胸腔内器官恶性肿瘤 | 骨和关节软骨恶性肿瘤
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Merck Sharp & Dohme LLC; National Institutes of...主动,不招人
-
Cao Pharmaceuticals Inc.The University of Texas Health Science Center at San Antonio未知
-
David BushnellNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective Therapeutics主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Vanderbilt-Ingram Cancer CenterEntrinsic Bioscience Inc.终止
-
Hospital Sao Rafael完全的霍奇金病 | 乳腺恶性肿瘤 | 结肠恶性肿瘤 | 非霍奇金淋巴瘤,滤泡性(结节性) | 支气管和肺部恶性肿瘤 | 继发性肿瘤恶性和性质不明的淋巴结 | 皮肤恶性黑色素瘤 | 小肠恶性肿瘤巴西
-
Gregory K. Friedman, MDMemorial Sloan Kettering Cancer Center; United States Department of Defense; Food and Drug Administration... 和其他合作者完全的
-
Diagnostica Stago R&DHopital Lariboisière; Hôpital Louis Mourier完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Nicholas Fidelman, MDMerck Sharp & Dohme LLC; BTG International Inc.主动,不招人
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人
-
Washington University School of MedicineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)完全的
-
Darell D. Bigner, MD, PhDNational Institute of Neurological Disorders and Stroke (NINDS)终止
-
Novartis Pharmaceuticals终止
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Chinese PLA General HospitalSinotau Pharmaceutical Group完全的
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
Boehringer Ingelheim完全的